Action FutureTech II Acquisition - FTII

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

11,44

Prix Achat

9,88

Prix Vente

12,97

Volume échangé

3 515

11,35 Fourchette du Jour 11,44

10,85 Plage de 52 semaines 12,48

Cap du marché

33,8M

Clôture Veille

11,3476

Ouverture

11,37

Dernière Transaction

11.5

Dernière heure de transaction

Volume financier

US$ 40 034

VWAP

11,3896

Volume moyen (3 m)

3 530

Actions en circulation

2 954 510

Rendement du Dividende

Ratio Cours sur Bénéfices

11,61

Bénéfice par action (BPA)

0,99

Chiffre d'affairess

Bénéfice net

2,91M

FutureTech II Acquisition Corp is a blank check company. FutureTech II Acquisition Corp is a blank check company.

Secteur

Blank Checks

Industrie

Blank Checks

Siège social

Wilmington, Delaware, USA

Fondé

FutureTech II Acquisition Corporation est coté dans le secteur Blank Checks de la NASDAQ avec le ticker FTII. Le dernier cours de clôture d'FutureTech II Acquisition était de US$11,35. Au cours de la dernière année, les actions de FutureTech II Acquisition ont été négociées dans une fourchette de prix de US$ 10,85 à US$ 12,48.

FutureTech II Acquisition compte actuellement 2 954 510 actions en circulation. La capitalisation boursière d'FutureTech II Acquisition est de US$33,53 million. FutureTech II Acquisition a un ratio cours/bénéfice (ratio PE) de 11.61.

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the “Company”) (NASDAQ: FTII), today announced that it...

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

-Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health...

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

New Rochelle, NY, May 17, 2023 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (Nasdaq: FTIIU) (the...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.21	1.86999109528	11.23	11.44	11.11	119	11.34363038	CS
4	-0.46	-3.86554621849	11.9	11.9894	11	5709	11.4023297	CS
12	0.37	3.342366757	11.07	12.48	11	3530	11.34106861	CS
26	0.42	3.8112522686	11.02	12.48	10.85	8162	11.14213097	CS
52	0.43	3.9055404178	11.01	12.48	10.85	8470	11.1301376	CS
156	1.49	14.9748743719	9.95	12.48	9.95	23712	10.53319045	CS
260	1.49	14.9748743719	9.95	12.48	9.95	23712	10.53319045	CS

FTII - Frequently Asked Questions (FAQ)

What is the current FutureTech II Acquisition share price?

The current share price of FutureTech II Acquisition is US$ 11,44

How many FutureTech II Acquisition shares are in issue?

FutureTech II Acquisition has 2 954 510 shares in issue

What is the market cap of FutureTech II Acquisition?

The market capitalisation of FutureTech II Acquisition is USD 33,53M

What is the 1 year trading range for FutureTech II Acquisition share price?

FutureTech II Acquisition has traded in the range of US$ 10,85 to US$ 12,48 during the past year

What is the PE ratio of FutureTech II Acquisition?

The price to earnings ratio of FutureTech II Acquisition is 11,61

What is the reporting currency for FutureTech II Acquisition?

FutureTech II Acquisition reports financial results in USD

What is the latest annual profit for FutureTech II Acquisition?

The latest annual profit of FutureTech II Acquisition is USD 2,91M

What is the registered address of FutureTech II Acquisition?

The registered address for FutureTech II Acquisition is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

Which industry sector does FutureTech II Acquisition operate in?

FutureTech II Acquisition operates in the BLANK CHECKS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
JTAIJet AI Inc	US$ 10,1006 (148,78%)	149,38M
EDITEditas Medicine Inc	US$ 3,19 (83,33%)	49,89M
SINTSiNtx Technologies Inc	US$ 4,79 (69,86%)	70,97M
LYTLytus Technologies Holdings PTV Ltd	US$ 0,363 (63,07%)	215,48M
AGHAureus Greenway Holdings Inc	US$ 3,8501 (42,07%)	1,02M
CNSPCNS Pharmaceuticals Inc	US$ 0,0838 (-41,19%)	88,17M
HCTIHealthcare Triangle Inc	US$ 0,4409 (-38,76%)	3,19M
NKLANikola Corporation	US$ 0,4711 (-38,49%)	110,5M
BPTHBio Path Holdings Inc	US$ 0,1322 (-37,05%)	2,14M
GLSTUGlobal Star Acquisition Inc	US$ 7,26 (-36,04%)	4,41k
ADTXAditxt Inc	US$ 0,1288 (17,09%)	612,1M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,0616 (13,03%)	482,51M
SMCISuper Micro Computer Inc	US$ 60,25 (7,97%)	338,03M
LYTLytus Technologies Holdings PTV Ltd	US$ 0,363 (63,07%)	215,48M
NVDANVIDIA Corporation	US$ 139,23 (-0,12%)	168,02M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FutureTech II Acquisition Corporation (FTII)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de FutureTech II Acquisition Corporation

FTII Dernières nouvelles

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FTII - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FutureTech II Acquisition Corporation (FTII) Cours

FutureTech II Acquisition Corporation (FTII)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de FutureTech II Acquisition Corporation

FTII Dernières nouvelles

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FTII - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités